Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer

Gynecologic Oncology

Volumn 133, Issue 3, 2014, Pages 485-493

  Alhilli, Mariam M ^a   Mariani, Andrea ^a   Bakkum Gamez, Jamie N ^a   Dowdy, Sean C ^a   Weaver, Amy L ^a   Peethambaram, Preema P ^a   Keeney, Gary L ^a   Cliby, William A ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endometrial cancer; High grade; Low grade; Nomogram; Overall survival

Indexed keywords

CISPLATIN DERIVATIVE; DOXORUBICIN; PACLITAXEL;

ABDOMINAL DISEASE; ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; INTRA ABDOMINAL DISEASE; LOW RISK PATIENT; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; NOMOGRAM; OVERALL SURVIVAL; PATIENT ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL PREDICTION; SYSTEMIC THERAPY;

ENDOMETRIAL CANCER; HIGH GRADE; LOW GRADE; NOMOGRAM; OVERALL SURVIVAL;

AGED; CARCINOMA; CARCINOMA, ENDOMETRIOID; CARDIOVASCULAR DISEASES; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; COMORBIDITY; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LUNG DISEASES; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84901673573     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.03.567     Document Type: Article

References (34)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 Jan 2013 11 30
2. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1 Feb 1983 10 17
3. W.T. Creasman, F. Odicino, P. Maisonneuve, M.A. Quinn, U. Beller, and J.L. Benedet et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl. 1 Nov 2006 S105 S143
4. K.K. Ward, N.R. Shah, C.C. Saenz, M.T. McHale, E.A. Alvarez, and S.C. Plaxe Cardiovascular disease is the leading cause of death among endometrial cancer patients Gynecol Oncol 126 2 Aug 2012 176 179
5. R.E. Schmandt, D.A. Iglesias, N.N. Co, and K.H. Lu Understanding obesity and endometrial cancer risk: opportunities for prevention Am J Obstet Gynecol 205 6 Dec 2011 518 525
6. K. Esposito, P. Chiodini, A. Colao, A. Lenzi, and D. Giugliano Metabolic syndrome and risk of cancer: a systematic review and meta-analysis Diabetes Care 35 11 Nov 2012 2402 2411
7. H. Arem, and M.L. Irwin Obesity and endometrial cancer survival: a systematic review Int J Obes (Lond) 37 5 May 2013 634 639
8. V.W. Setiawan, H.P. Yang, M.C. Pike, S.E. McCann, H. Yu, and Y.B. Xiang et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31 20 Jul 10 2013 2607 2618
9. C.A. Hamilton, M.K. Cheung, K. Osann, L. Chen, N.N. Teng, and T.A. Longacre et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers Br J Cancer 94 5 Mar 13 2006 642 646
10. J. Prat Prognostic parameters of endometrial carcinoma Hum Pathol 35 6 Jun 2004 649 662
11. J.M. Meyer, and G.S. Ginsburg The path to personalized medicine Curr Opin Chem Biol 6 4 Aug 2002 434 438
12. S. Polterauer, Q. Zhou, C. Grimm, V. Seebacher, A. Reinthaller, and G. Hofstetter et al. External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer Gynecol Oncol 125 3 Jun 2012 526 530
13. A. Iasonos, D. Schrag, G.V. Raj, and K.S. Panageas How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 8 Mar 10 2008 1364 1370
14. P.M. Ravdin, L.A. Siminoff, G.J. Davis, M.B. Mercer, J. Hewlett, and N. Gerson et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 4 Feb 15 2001 980 991
15. J.S. Michaelson, R. Moore, A. Garland, S. Satija, E.F. Halpern, and D.B. Kopans Computer simulation estimates of the consequences of various breast cancer screening strategies Radiology 213P Nov 1999 240 241
16. M.W. Kattan, A.M.F. Stapleton, T.M. Wheeler, and P.T. Scardino Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma Cancer 79 3 Feb 1 1997 528 537
17. N.R. Abu-Rustum, Q. Zhou, J.D. Gomez, K.M. Alektiar, M.L. Hensley, and R.A. Soslow et al. A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care Gynecol Oncol 116 3 Mar 2010 399 403
18. J.A. Ferreiro, J.L. Myers, and D.G. Bostwick Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester Mayo Clin Proc 70 12 Dec 1995 1137 1141
19. A. Mariani, S.C. Dowdy, W.A. Cliby, B.S. Gostout, M.B. Jones, and T.O. Wilson et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging Gynecol Oncol 109 1 Apr 2008 11 18
20. A. Mariani, M.J. Webb, G.L. Keeney, M.G. Haddock, G. Calori, and K.C. Podratz Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182 6 Jun 2000 1506 1519
21. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2 May 2009 103 104
22. R. Scully, T. Bonfiglio, R. Kurman, S. Silverberg, and E. Wilkinson WHO - histological typing of female genital-tract tumors Ann Pathol 15 4 1995 296 297
23. B.L. Hall, B.H. Hamilton, K. Richards, K.Y. Bilimoria, M.E. Cohen, and C.Y. Ko Does surgical quality improve in the American college of surgeons national surgical quality improvement program an evaluation of all participating hospitals Ann Surg 250 3 Sep 2009 363 376
24. S.F. Khuri, J. Daley, and W.G. Henderson The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs Arch Surg 137 1 Jan 2002 20 27
25. S.M. Strasberg, D.C. Linehan, and W.G. Hawkins The accordion severity grading system of surgical complications Ann Surg 250 2 Aug 2009 177 186
26. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 4 Feb 28 1996 361 387
27. J.N. Bakkum-Gamez, A. Mariani, S.C. Dowdy, A.L. Weaver, M.E. McGree, and J.R. Martin et al. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy Gynecol Oncol 132 1 2014 194 202
28. A.A. Secord, M.A. Geller, G. Broadwater, R. Holloway, K. Shuler, and N.Y. Dao et al. A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer Gynecol Oncol 128 1 Jan 2013 65 70
29. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 1 Jan 1 2006 36 44
30. T. Hogberg, M. Signorelli, C.F. de Oliveira, R. Fossati, A.A. Lissoni, and B. Sorbe et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies Eur J Cancer 46 13 Sep 2010 2422 2431
31. S.C. Dowdy, B.J. Borah, J.N. Bakkum-Gamez, S. Kumar, A.L. Weaver, and M.E. McGree et al. Factors predictive of postoperative morbidity and cost in patients with endometrial cancer Obstet Gynecol 120 6 Dec 2012 1419 1427
32. J.N. Bakkum-Gamez, S.C. Dowdy, B.J. Borah, L.R. Haas, A. Mariani, and J.R. Martin et al. Predictors and costs of surgical site infections in patients with endometrial cancer Gynecol Oncol 130 1 Jul 2013 100 106
33. M.K. Gould, D.A. Garcia, S.M. Wren, P.J. Karanicolas, J.I. Arcelus, and J.A. Heit et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl. Feb 2012 e227S e277S
34. J.W. Alexander, J.S. Solomkin, and M.J. Edwards Updated recommendations for control of surgical site infections Ann Surg 253 6 Jun 2011 1082 1093